Sagar Lonial Discusses Treating Patients With Myeloma
Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.
Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.
Lonial says that care should be directed by a myeloma expert who can define a treatment plan over the next 6 to 12 months.
While new treatment options for myeloma have recently emerged, Lonial says it’s important for providers to know when to treat and when not treat with a new drug. He adds that patients should be encouraged to admit any adverse events, particularly neuropathy or fatigue, which can impact quality of life.
